PharmSource – CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2019 Edition

Research By Markets adds Market Research Report - PharmSource – CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2019 Edition

For detailed information:

PharmSource – CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2019 Edition


This report is the 9th edition of our long running analysis of the CMO Industry, using NDA approvals as the primary indicator of performance. CMO Scorecard is critical for benchmarking the performance of the CMO industry and the relative performance of major CMOs.


– This 50-page report gives important, expert insight you won’t find in any other source. 32 tables and figures throughout the report illustrate major points and trends. This report is required reading for:
– CMO executives who must have deep understanding of the injectables marketplace to make strategic planning and investment decisions.
– Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
– Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to buy

– Overview of NDA drug approvals and the levels of outsourcing associated with NDA sub segments
– Detailed view of CDMO performance by number of approvals and an assessment of their sponsors market caps from the PharmSource Contract Service Providers database
– Outsourcing propensity for NMEs, different dosage forms and by sponsor company cap have all been assessed.
– Analysis of NME special products approvals such as those with Orphan, Breakthrough or Fast Track designations and assessment of outsourcing

Companies Mentioned:
3M Drug Delivery Systems, AbbVie Inc, ABF Pharmaceutical Services GmbH, ACS Dobfar SPA, Adare Pharmaceuticals Inc, Adoh BV, Aenova Holding GmbH, Aesica Pharmaceuticals Ltd, Afton Scientific Corp, Ajinomoto Althea Inc, Ajinomoto Co Inc, Akorn Inc, Albany Molecular Research Inc, Alcami Corp, Alkermes Plc, Allergan Plc, Alliance Contract Pharma LLC, Almac Group Ltd, Alpex Pharma SA, Apotex Inc, Aquestive Therapeutics Inc, ARx LLC, ASM – Aerosol-Service AG, AstraZeneca Plc, AustarPharma LLC, Avara Pharmaceutical Services Inc, Bausch & Lomb Pharmaceuticals Inc, Bausch Health Companies, Baxter Biopharma Solutions, Bayer AG, BioRamo LLC, Boehringer Ingelheim Bioxcellence, Boehringer Ingelheim GmbH, Cadila Healthcare Ltd, Capsugel Inc, Catalent Inc, Cenexi SAS, Centre for Probe Development and Commercialization, Cerovene Inc, Cipla Ltd, Confab Laboratories Inc, Contract Pharmaceuticals Ltd, Delpharm SAS, Dexcel PT Israel Ltd, DPT Laboratories Ltd, Ei A Pharmaceutical SolutionWorks (TM), Eisai Co Ltd, Emergent BioSolutions Inc, Excella GmbH & Co KG, Exela Pharma Sciences LLC, Fareva SA, Fresenius Kabi Product Partnering, Fritz Keller Holding AG, Galephar Pharmaceutical Research Inc, Gilead Sciences Inc, Gland Pharma Ltd, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd, Grifols SA, Groupe Synerlab SAS, Grunenthal GmbH, Halo Pharma Inc, Hameln Pharmaceuticals GmbH, Hikma Pharmaceuticals Plc, Holopack Verpackungstechnik GmbH, Hovione FarmaCiencia SA, Importfab Inc, Institutt for Energiteknikk, Insud Pharma, Intas Pharmaceuticals Ltd, James Alexander Corp., Jubilant HollisterStier Contract Manufacturing & Services, Kemwell Biopharma Pvt Ltd, KP Pharmaceutical Technology Inc, Kyowa Hakko Kirin Co Ltd, Laboratoires PANPHARMA SA, Laboratoires Pierre Fabre SA, Laboratoires Thea SA, Lifecore Biomedical LLC, LTS Lohmann Therapie-Systeme AG, Lyne Laboratories, Lyophilization Services of New England Inc, Merck & Co Inc, Mikart Inc, Mipharm SpA, Mitsubishi Tanabe Pharma Corp, Mylan NV, Napp Pharmaceuticals Ltd, Neolpharma SA De CV, Nexgen Pharma Inc, NextPharma Technologies Holding Ltd, Nordmark Arzneimittel GmbH & Co KG, Norwich Pharma Services, Novast Holdings Ltd, Nuvo Pharmaceuticals Inc, OishiKoseido Corp, Orion Corp, OSO BioPharmaceuticals Manufacturing LLC, Paras Biopharmaceuticals Finland Oy, PARI Pharma GmbH, Patheon NV, PCI Pharma Services, Perrigo Co Plc, Pfizer Inc, Pharmaceutical Manufacturing Research Services Inc, Pharmaceutics International Inc, Pharmascience Inc, Pharmasol Corp, Pierrel Spa, Pillar5 Pharma Inc, Propak Health Ltd, QPharma AB, Quotient Sciences Ltd, Rechon Life Science AB, Recipharm AB, Recro Pharma Inc, Renaissance Pharma Inc, Rentschler Biotechnologie GmbH, Rivopharm SA, Rosemont Pharmaceuticals Ltd, Rottendorf Pharma GmbH, Sanico NV, Sanofi, Sharp Packaging Services, Shire Plc, Siegfried Holding AG, Sintetica SA, Sirton Pharmaceuticals SpA, Sterigenics International, Steri-Pharma LLC, Synergy Health Ltd, Tapemark Co, Teligent Inc, Teva Pharmaceutical Industries Ltd, The Ritedose Corp, Therapure Biopharma Inc, Torii Pharmaceutical Co Ltd, Tris Pharma Inc, UCB SA, Unither Pharmaceuticals, University of Iowa Pharmaceuticals, UPM Pharmaceuticals Inc, USV Pvt Ltd, Vectura Group Plc, Vetter Pharma-Fertigung GmbH & Co KG, Vianex SA, Vifor Pharma AG, Woodfield Pharmaceutical LLC, Zymeworks Inc

For queries regarding this report:

Contact Us:
Sales Desk
USA: +1-800-416-3124

Follow us on Social Media:

Ritesh Tiwari is the Founder of Research By Markets, a leading Market Research Reports Reseller trusted by Fortune listed companies for their requirements of Syndicated and Custom Market Research Reports. Ritesh has an overall experience of 18+ years in Recruitments, Sales and Operations. He has been associated with the Market Research industry for the past 7 years. He is an avid foodie as well as a huge football fan being a supporter of Manchester United (EPL) and FC Barcelona (La Liga). Get in touch with him via *Market Research News is a part of Research By Markets.